|
 Twenty people have already died from hemorrhagic fevers in and
around Mangina, a densely populated town about 30 km (18 miles)
southwest of the city of Beni and 100 km from the Ugandan border,
the ministry said in its statement, without saying when the deaths
occurred.
A team of 12 experts from Congo's health ministry will arrive in
Beni on Thursday to set up a mobile lab, the ministry said. The
World Health Organization has started moving staff and supplies to
the area, WHO chief Tedros Adhanom Ghebreyesus said.
They head to a region where deep security problems could complicate
efforts to contain the virus. About 1,000 civilians have been killed
by armed groups and government soldiers around Beni since 2014, and
the wider region of North Kivu holds over 1 million displaced
people.
"This is an active conflict zone. The major barrier will be safely
accessing the affected population," Peter Salama, WHO Deputy
Director-General of emergency preparedness and response, said in a
statement.
Jeremy Konyndyk, an aid expert at the Center for Global Development,
said other recent Ebola outbreaks had fortunately been in relatively
safe and stable areas.
"North Kivu is a different story, which makes me a little nervous,"
he said.
The area also has strong trade with neighboring Rwanda and Uganda,
raising the risk of the virus moving internationally.
Julie Hall, chief of staff at the International Federation of the
Red Cross, said the Ebola response in North Kivu would be a "highly
complex" operation.
The ministry said no evidence linked this outbreak with the last
one, which began in April and occurred over 2,500 km (1,553 miles)
away in northwestern Congo.
BATS AND BODY FLUIDS
This is the central African country's 10th outbreak since 1976, when
the virus was discovered near the eponymous Ebola river in the
north. That is more than twice as many as any other country.
[to top of second column] |
Ebola is believed to be spread over long distances by bats and can
turn up in bush meat sold at food markets throughout Congo. Once
present in humans, it causes hemorrhagic fever, vomiting and
diarrhea and is spread through direct contact with body fluids.
An outbreak concentrated in the West African countries of Sierra
Leone, Liberia and Guinea killed at least 11,300 people between 2013
and 2016.
Congolese and international health officials were credited with
responding rapidly to the last outbreak, including by deploying an
experimental vaccine manufactured by Merck, one of several vaccines
being developed against Ebola.
But the Merck vaccine is designed to be used against the Zaire
strain of Ebola, and there has been no confirmation of the strain in
the latest outbreak, with the WHO calling it only "presumptive
Ebola".
A WHO spokesman declined to comment on possible vaccine use.
Aside from the vaccine, the key factors in halting the previous
outbreak appeared to be aggressive tracing of potential patients and
the speed of the response.
The WHO said the fact that it already had staff and equipment in
place would give it a head start against the new outbreak.
"Ebola is a constant threat in DRC. What adds to our confidence in
the country's ability to respond is the transparency they have
displayed once again," WHO head Tedros said.
"We will fight this one as we did the last."
(Additional reporting by Tom Miles in Geneva; Writing by Aaron Ross
and Edward McAllister; Editing by Matthew Mpoke Bigg)
[© 2018 Thomson Reuters. All rights
reserved.] Copyright 2018 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |
